MARICO - Fundamental Analysis: Financial Health & Valuation
Back to ListFundamental Rating: 3.7
| Stock Code | MARICO | Market Cap | 1,07,143 Cr. | Current Price | 825 ₹ | High / Low | 849 ₹ |
| Stock P/E | 55.2 | Book Value | 44.7 ₹ | Dividend Yield | 1.27 % | ROCE | 41.5 % |
| ROE | 36.7 % | Face Value | 1.00 ₹ | DMA 50 | 792 ₹ | DMA 200 | 750 ₹ |
| Chg in FII Hold | 0.06 % | Chg in DII Hold | -0.06 % | PAT Qtr | 336 Cr. | PAT Prev Qtr | 441 Cr. |
| RSI | 58.4 | MACD | 16.8 | Volume | 10,33,878 | Avg Vol 1Wk | 14,75,644 |
| Low price | 680 ₹ | High price | 849 ₹ | PEG Ratio | 3.05 | Debt to equity | 0.03 |
| 52w Index | 85.9 % | Qtr Profit Var | 3.38 % | EPS | 15.0 ₹ | Industry PE | 20.5 |
📊 Core Financials: Marico reported quarterly PAT of ₹336 Cr (down from ₹441 Cr), showing a decline in profitability. ROE at 36.7% and ROCE at 41.5% highlight excellent efficiency. Debt-to-equity ratio of 0.03 indicates a nearly debt-free balance sheet. EPS at ₹15.0 is modest relative to market cap, reflecting limited earnings expansion despite strong efficiency.
💹 Valuation Indicators: Stock P/E of 55.2 is significantly higher than the industry average (20.5), suggesting overvaluation. Book value at ₹44.7 vs CMP ₹825 shows a steep premium. PEG ratio of 3.05 indicates earnings growth is slower relative to valuation. Intrinsic value appears lower than CMP, limiting near-term upside potential.
🏭 Business Model & Advantage: Marico operates in FMCG with strong brands in hair care, edible oils, and wellness products. Competitive advantage lies in brand loyalty, distribution strength, and innovation in health-focused categories. However, high valuations and modest EPS growth reduce attractiveness.
📈 Entry Zone & Holding Guidance: The stock trades above DMA 50 (₹792) and DMA 200 (₹750), showing strong momentum. RSI at 58.4 indicates mildly overbought conditions. A better entry zone would be closer to ₹780–₹800. Long-term holding is viable given brand strength and efficiency, but valuation risks must be monitored.
Positive
- ✅ Strong ROE (36.7%) and ROCE (41.5%) efficiency
- ✅ Debt-to-equity ratio at 0.03, nearly debt-free
- ✅ Dividend yield at 1.27%, providing income support
- ✅ FII holding increased slightly (+0.06%), showing foreign investor confidence
Limitation
- ⚠️ Quarterly PAT decline (₹441 Cr → ₹336 Cr)
- ⚠️ Very high P/E (55.2) vs industry average (20.5)
- ⚠️ PEG ratio of 3.05, showing slower earnings growth relative to valuation
Company Negative News
- 📉 DII holding decreased by 0.06%, showing cautious domestic institutional sentiment
Company Positive News
- 📈 Strong brand presence and diversified FMCG portfolio
- 📈 Efficiency metrics (ROE, ROCE) remain among the best in the sector
Industry
- 🌐 FMCG industry PE at 20.5, reflecting moderate valuations compared to Marico’s premium
- 🌐 Long-term demand supported by consumer staples and wellness trends
Conclusion
🔎 Marico is fundamentally strong with excellent efficiency, strong brands, and low debt. However, high valuations and declining quarterly profits limit near-term attractiveness. Entry near ₹780–₹800 offers better risk-reward. Long-term investors may hold cautiously, supported by brand strength and industry demand, but valuation risks must be monitored.
For deeper insights, you could explore a peer comparison or a valuation analysis to assess its position against competitors and intrinsic value.